Fidia Farmaceutici is an API and finished-dose manufacturer based in Italy. It holds 7 valid CEPs across a filed portfolio of 2 molecules. Its filings concentrate with AIFA (IT), EMA and AEMPS (ES). Its GMP standing is certified by EMA, ANVISA (Brazil) and EAEU_EEC. Its most recent recorded inspection, by US FDA, closed on 2 July 2009 as VAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Abano Terme (Padua), United Arab Emirates | Not on file |
| Padova, United Arab Emirates | Not on file |
| 20037, United Arab Emirates | Not on file |
| ABANO TERME, Italy | Not on file |
| - DIVISIONE SOLMAG Abano Terme, Italy | Not on file |
| NOTO, Italy | Not on file |
5 further sites are on record.
| Molecule | Regulators | Docs |
|---|---|---|
| Sodium Hyaluronate | EDQM | 7 |
| Tretinoin | SFDA (Saudi Arabia) | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| AIFA (IT) | 153 | None |
| EMA | 39 | 3 |
| AEMPS (ES) | 19 | None |
| EDE (AE) | 14 | None |
| DPM (TN) | 10 | None |
| SFDA (Saudi Arabia) | 6 | None |
| ANVISA (Brazil) | None | 3 |
| EAEU_EEC | None | 1 |
Choose your molecules and target markets. Fidia Farmaceutici comes back tiered against every other supplier able to file there.
Start for free